本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Addex Therapeutics Ltd

9.38
+0.24502.68%
盘后9.28-0.0950-1.01%13:00 EDT
成交量:2.90万
成交额:27.56万
市值:1,002.28万
市盈率:1.25
高:9.89
开:9.69
低:8.99
收:9.13
数据加载中...
2023/02/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/11/23

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/11/09

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/25

SEC问询函

CORRESP [Cover] - Correspondence
2022/08/23

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/19

招股说明书

F-1 - Registration statement for certain foreign private issuers
2022/08/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/29

SEC问询函

CORRESP [Cover] - Correspondence
2022/03/10

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/18

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/14

SEC问询函

CORRESP [Cover] - Correspondence
2022/01/10

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/01/07

招股说明书

F-1 - Registration statement for certain foreign private issuers
2021/09/08

超过5%披露

Addex Therapeutics Ltd.
2021/04/12

SEC问询函

CORRESP [Cover] - Correspondence